Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-22-019395)

Filing Details

Accession Number:: 0000899243-22-019395
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-24 19:00:12
Reporting Period:: 2022-05-20

Accepted Time:: 2022-05-24 19:00:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1635088	Roivant Sciences Ltd.	ROIV	Pharmaceutical Preparations (2834)	981173944

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1856296	Rakhi Kumar	C/O Roivant Sciences Ltd. 11-12St. James'S Square, Ste 1, 3Rd Fl London X0 SW1Y 4LB	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2022-05-20	12,127	$3.70	147,656	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.